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To understand howMiddle East respiratory syndrome coronavirus (MERS-CoV) transmitted from bats to humans, we com-
pared the virus surface spikes of MERS-CoV and a related bat coronavirus, HKU4. Although HKU4 spike cannot mediate viral
entry into human cells, twomutations enabled it to do so by allowing it to be activated by human proteases. These mutations are
present inMERS-CoV spike, explaining whyMERS-CoV infects human cells. These mutations therefore played critical roles in
the bat-to-human transmission of MERS-CoV, either directly or through intermediate hosts.
Since its emergence in 2012, Middle East respiratory syndromecoronavirus (MERS-CoV) has infected over 1,100 people,
with a case fatality rate of 38% (1, 2). Bats are considered the
natural reservoir of MERS-CoV because several coronaviruses,
including HKU4, have been isolated from bats and are genetically
related to MERS-CoV (3–5). An envelope-anchored spike protein
mediates coronavirus entry into host cells. It first binds a host
receptor through its S1 subunit and then fuses membranes
through its S2 subunit (6–8). For membrane fusion, the spike
must be cleaved at the S1/S2 boundary by one or more host pro-
teases (9–13). We recently showed that both HKU4 and MERS-
CoV spikes recognize host receptor dipeptidyl peptidase 4 (DPP4)
(14). Furthermore, only MERS-CoV spike, and not HKU4 spike,
mediates viral entry into human cells because the former, but not
the latter, can be activated by human endogenous proteases (14).
Here we further identified two residue differences between the two
spikes that account for their different capabilities to mediate viral
entry into human cells. Our results have revealed a likely evolu-
tionary pathway for the emergence of MERS-CoV as a human
pathogen, either from bats directly or through intermediate hosts.
By comparing the sequences of MERS-CoV and HKU4 spikes,
we identified two regions in MERS-CoV spike that may serve as
human protease target motifs but that differ from the correspond-
ing regions in HKU4 spike (Fig. 1). The first region is a motif for
human proprotein convertases (hPPC motif) (15, 16), but the
critical Arg748 in MERS-CoV spike corresponds to Ser746 in the
HKU4 spike, which deviates from the hPPC motif. The second
region is a motif for human endosomal cysteine proteases (hECP
motif) (17, 18), but the motif Ala763-Phe764-Asn765 in MERS-
CoV spike corresponds to Asn762-Tyr763-Thr764 in HKU4
spike, which likely introduces an N-linked glycosylation site and
blocks the access of human endosomal cysteine proteases. These
residue differences in the two human protease motifs between
MERS-CoV and HKU4 spikes may affect the capabilities of the
spikes to mediate viral entry into human cells.
To evaluate the potential genetic changes required for HKU4
to infect human cells, we reengineered HKU4 spike, aiming to
build its capacity to mediate viral entry into human cells. To this
end, we introduced two single mutations, S746R and N762A, into
HKU4 spike. The S746R mutation was expected to restore the
hPPC motif in HKU4 spike, whereas the N762A mutation likely
disrupted the potential N-linked glycosylation site in the hECP
motif in HKU4 spike. To confirm that the S746R mutation re-
stored the hPPC motif, we produced retroviruses pseudotyped
with HKU4 spike (referred to as HKU4 pseudoviruses) in human
cells and showed that HKU4 spike containing the S746R mutation
was partially cleaved during the molecular maturation process,
whereas wild-type HKU4 spike remained intact (Fig. 2A). Con-
firming that the N762A mutation disrupted the N-linked glycosy-
lation site in the hECP motif was technically challenging because
of the large size and heavy glycosylation of HKU4 spike (the trim-
eric HKU4 spike has 78 predicted N-linked glycosylate sites and a
total molecular mass of530 kDa). Nevertheless, we managed to
identify a slight downward shift of HKU4 spike with the N762A
mutation using Western blot analysis (Fig. 2B), consistent with
successful removal of the N-linked glycosylation site. We do not
currently have direct evidence to show that the spikes are cleaved
right at the hPPC and hECP motifs by human proteases. However,
both of the hPPC and hECP motifs in the spikes have been well
documented to be the cleavage sites for human proteases (16–18).
Moreover, mutations in these motifs in coronavirus spikes have
demonstrated dramatic effects on viral entry into human cells (see
below). Thus, the identified hPPC and hECP motifs are likely to
be cleaved by human proteases, although we cannot completely
rule out the possibility that alteration of these motifs may affect
protease cleavages at a spatially adjacent site on the spikes. In
either case, our study revealed that both of these motifs play crit-
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ical roles in HKU4- and MERS-CoV-spike-mediated entry into
human cells (see below).
We examined the capability of the mutant HKU4 spike to
mediate viral entry into three types of human cells (Fig. 3A for
HEK293T cells; data not shown for Huh-7 and MRC-5 cells),
using a pseudovirus entry assay as previously described (14). In
the absence of exogenous protease trypsin, HKU4 pseudovi-
ruses bearing either the reengineered hPPC motif or the reen-
gineered hECP motif were able to enter human cells, whereas
HKU4 pseudoviruses bearing both of the reengineered human
protease motifs entered human cells as efficiently as when ac-
tivated by exogenous trypsin (Fig. 3A). In contrast, wild-type
HKU4 pseudoviruses failed to enter human cells. Therefore,
the reengineered hPPC and hECP motifs enabled HKU4 spike
to be activated by human endogenous proteases and thereby
allowed HKU4 pseudoviruses to bypass the need for exogenous
proteases to enter human cells. These results reveal that HKU4
spike needs only two single mutations at the S1/S2 boundary to
gain the full capacity to mediate viral entry into human cells.
To confirm the functions of the reengineered human pro-
tease motifs in HKU4 spike, we used protease inhibitors to
probe the human proteases that activate HKU4-spike-medi-
ated viral entry into human cells. Human proprotein conver-
tase (PPC) inhibitor and endosomal cysteine protease (ECP)
inhibitor both blocked human cell entry of HKU4 pseudovi-
ruses bearing the reengineered hPPC motif and the reengi-
neered hECP motif, respectively (Fig. 3B). This result verified
that the gained capability of HKU4 pseudoviruses to enter hu-
man cells was due to the reengineered human protease motifs
in HKU4 spike.
To investigate the functions of the two human protease motifs
in MERS-CoV-spike-mediated entry into human cells, we reengi-
neered MERS-CoV spike in the opposite way, aiming to reduce or
eliminate its capability to mediate viral entry into human cells. To
this end, we introduced an R748S single mutation and A763N/
F764Y/N765T triple mutations into MERS-CoV spike (Fig. 1).
The R748S mutation destroyed the hPPC motif in MERS-CoV
spike (Fig. 2A), whereas the A763N/F764Y/N765T triple muta-
tions successfully added an N-linked glycosylation site to the
hECP motif in MERS-CoV spike (Fig. 2C). MERS-CoV pseudo-
FIG 1 Domain structure of MERS-CoV and HKU4 spike proteins. The spikes
contain a receptor-binding S1 subunit, a membrane-fusion S2 subunit, a
transmembrane anchor (TM), and an intracellular tail (IC). S1 contains the
receptor-binding domain (RBD) that binds DPP4 receptor. S2 contains the
fusion peptide (FP), heptad repeat 1 (HR1), and heptad repeat 2 (HR2), all of
which are essential structural elements for the membrane fusion process. The
S1/S2 boundary in MERS-CoV spike (defined as the region between the RBD
and the fusion peptide) contains one established human protease motif that is
recognized by proprotein convertases (hPPC) (15, 16); it also contains one
established human protease motif that is recognized by endosomal cysteine
proteases (hECP) (17, 18). Sequence alignments of these regions in MERS-
CoV and HKU4 spikes (GenBank accession no. AFS88936.1 for MERS-CoV
spike; ABN10839.1 for HKU4 spike) are shown, with the critical residue dif-
ferences labeled in red. Arrows indicate the predicted sites of cleavage by hu-
man proteases in MERS-CoV spike.
FIG 2 Characterization of two protease motifs in MERS-CoV and HKU4
spike proteins. (A) Western blot analysis of HKU4 and MERS-CoV spikes in
pseudovirus particles. Retroviruses pseudotyped with HKU4 spike (i.e., HKU4
pseudoviruses) or MERS-CoV spike (i.e., MERS-CoV pseudoviruses) were
prepared in HEK293T (human embryonic kidney) cells as previously de-
scribed (14). The incorporations of wild-type (WT) and mutant HKU4 and
MERS-CoV spikes into pseudovirus particles were measured by Western blot-
ting using antibody against their C-terminal C9 tags. Plots below the Western
blot images correspond to quantifications of the band intensities from the
cleaved and uncleaved spikes combined. The numbers below the plots indicate
the relative amounts of spikes incorporated into pseudovirus particles com-
pared to wild-type HKU4 and MERS-CoV spikes, respectively. All quantifica-
tions were done using ImageJ software (National Institutes of Health). (B)
Glycosylation state of HKU4 spike at the hECP motif. HEK293T cells exoge-
nously expressing wild-type (WT) and mutant HKU4 spikes were lysed and
subjected to Western blot analysis. To improve the separation of high-molec-
ular-mass spikes, 3 to 8% NuPAGE Tris-acetate gels (Life Technologies) were
used for gel electrophoresis. To improve the accuracy of the result, each of the
mutant and wild-type spikes was run in two lanes that alternated between
samples. The experiment was also repeated in a separate gel. Compared with
wild-type HKU4 spike, the downward shift in the band of HKU4 spike bearing
the mutated hECP motif (i.e., mutation N762A) is consistent with the removal
of glycosylation. (C) Glycosylation state of MERS-CoV spike at the hECP
motif. Compared with MERS-CoV spike bearing the reengineered hPPC motif
(i.e., mutation R748S), the upward shift in the band of MERS-CoV spike
bearing both the reengineered hPPC and hECP motifs (i.e., mutations R748S/
A763N/F764Y/N765T) indicates the introduction of glycosylation.
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viruses bearing either the mutated hPPC motif or the mutated
hECP motif demonstrated a decreased capability to enter three
types of human cells (Fig. 3C for HEK293T cells; data not shown
for Huh-7 and MRC-5 cells). MERS-CoV pseudoviruses bearing
both of the mutated human protease motifs were unable to enter
human cells. Exogenous trypsin was able to fully rescue the capa-
bility of mutant MERS-CoV pseudoviruses to enter human cells.
Moreover, PPC inhibitor and ECP inhibitor both blocked human
cell entry of wild-type MERS-CoV pseudoviruses but had no effect
on human cell entry of MERS-CoV pseudoviruses bearing the
mutant hPPC motif and the mutant hECP motif, respectively (Fig.
3D). Thus, the mutations in the hPPC and hECP motifs together
eliminated MERS-CoV-spike-mediated viral entry into human
cells. These results demonstrate that the two functional human
protease motifs in MERS-CoV spike played a critical role in the
bat-to-human transmission of MERS-CoV.
After examining HKU4- and MERS-CoV-spike-mediated viral
entry into human cells, we investigated how these spikes mediate
viral entry into bat cells. Because of the low transfection efficiency
of bat cells, we were unable to package pseudoviruses in bat cells.
Instead, we packaged HKU4 and MERS-CoV pseudoviruses in
HEK293T cells and subsequently performed HKU4- and MERS-
CoV-spike-mediated pseudovirus entry into two types of bat cells:
RSKT (Rhinolophus sinicus bat kidney cells) and Tb1-Lu cells (Ta-
darida brasiliensis bat lung cells) (Fig. 4). Wild-type HKU4 pseu-
doviruses entered bat cells efficiently, whereas HKU4 pseudovi-
ruses bearing the reengineered hECP motif (which removed the
N-linked glycosylation site) demonstrated an enhanced capability
to enter bat cells (Fig. 4A and B). On the other hand, wild-type
MERS-CoV pseudoviruses entered bat cells efficiently, whereas
MERS-CoV pseudoviruses bearing the mutant hECP motif
(which added the N-linked glycosylation site) demonstrated a re-
duced, but still significant, capability to enter bat cells (Fig. 4C and
D). Moreover, most of HKU4- and MERS-CoV-spike-mediated
pseudovirus entry into bat cells could be blocked by the ECP in-
hibitor, also suggesting that bat endosomal cysteine proteases ac-
tivate coronavirus spikes bearing a glycosylated hECP motif (Fig.
4). These results indicate that, unlike human endosomal cysteine
proteases, bat endosomal cysteine proteases are capable of recog-
nizing and efficiently cleaving the hECP motif containing a glyco-
FIG 3 HKU4- and MERS-CoV-spike-mediated pseudovirus entry in human cells. (A) HKU4 pseudoviruses bearing no mutation, the reengineered hPPC motif
(S746R), the reengineered hECP motif (N762A), or both of the reengineered motifs (S746R/N762A) were prepared in HEK293T (human embryonic kidney) cells
and were then used to infect HEK293T cells exogenously expressing human DPP4 (GenBank accession no. NP_001926.2). The infections were carried out in the
presence or absence of exogenous trypsin. The pseudovirus entry efficiencies were characterized by analysis of the levels of luciferase activity accompanying the
entry and were normalized against the relative amounts of spikes incorporated into pseudovirus particles (Fig. 2A). The pseudovirus entry mediated by HKU4
spike bearing both of the reengineered motifs in the absence of exogenous trypsin was taken as 100%. (B) Pseudovirus-producing HEK293T cells were treated
with proprotein convertase (PPC) inhibitor (dec-RVKR-CMK) 5 h after transfection of plasmids that encode HKU4 spike containing the reengineered hPPC
motif (S746R). Pseudovirus-targeting HEK293T cells were treated with endosomal cysteine protease (ECP) inhibitor (E-64d) before being infected by HKU4
pseudoviruses bearing the reengineered hECP motif (N762A). Both of the inhibitors were used for HKU4 pseudoviruses bearing both of the mutations. (C)
MERS-CoV pseudoviruses bearing no mutation, the mutated hPPC motif (R748S), the mutated hECP motif (A763N/F764Y/N765T), or both of the mutated
motifs (R748S/A763N/F764Y/N765T) were used to infect HEK293T cells exogenously expressing human DPP4. The pseudovirus entry mediated by the
wild-type MERS-CoV spike in the absence of exogenous trypsin was taken as 100%. (D) Pseudovirus-producing HEK293T cells were treated with dec-RVKR-
CMK 5 h after transfection of plasmids that encode MERS-CoV spike containing the mutated hPPC motif (R748S). Pseudovirus-targeting HEK293T cells were
treated with E-64d before being infected by MERS-CoV pseudoviruses bearing the mutated hECP motif (A763N/F764Y/N765T). Both of the inhibitors were used
for MERS-CoV pseudoviruses bearing both of the mutated motifs. Error bars indicate standard errors of the means (SEM) (n 4).
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sylation site. The molecular and structural differences between
human and bat hECPs accounting for their functional differences
will be investigated in future research.
Understanding the molecular mechanisms for cross-species
transmissions of viruses is critical for evaluating their emerging
disease potentials and for preventing or controlling their spread in
human populations. Here we examined the different cell entry
activities of the spike proteins from human-infecting MERS-CoV
and a closely related bat coronavirus, HKU4. Although MERS-
CoV and HKU4 spikes share high sequence homology and recog-
nize the same host DPP4 receptor, only MERS-CoV spike, and not
HKU4 spike, mediates viral entry into human cells. Our study
revealed that introduction of two single mutations, S746R and
N762A, into HKU4 spike at the S1/S2 boundary fully instilled its
capability to mediate viral entry into human cells. MERS-CoV
spike already contained both of these mutations, explaining why
MERS-CoV is capable of infecting human cells. Thus, these two
mutations in the spike are essential for MERS-CoV to transmit
from bats to humans by allowing MERS-CoV spike to be activated
by human cellular proteases. Viral adaptation to human cellular
proteases is critical for viral infection of human cells because hu-
man cellular proteases, particularly endosomal proteases, are
more reliable sources than some extracellular proteases to activate
viral entry. Previous research also identified two mutations in
SARS-CoV spike that led SARS-CoV to transmit from palm civets
to humans (19–22). These mutations increased the capability of
SARS-CoV spike to bind human receptor angiotensin-converting
enzyme 2. Thus, different entry factors appear to have played the
most critical roles in the cross-species transmission of MERS-CoV
and SARS-CoV: adaption to human cellular proteases by MERS-
CoV and adaption to human receptor by SARS-CoV. Although
MERS-CoV spike might also need to adapt to human DPP4 re-
ceptor upon infecting human cells (14, 23), such adaptations
might have only incremental effects on the infectivity of MERS-
CoV in human cells. In contrast, the two mutations adaptive to
human cellular proteases transformed MERS-CoV spike from
completely lacking to fully possessing the capacity to mediate viral
entry into human cells, and thus they likely played the most critical
role in the bat-to-human transmission of MERS-CoV, either di-
rectly or through intermediate hosts.
ACKNOWLEDGMENTS
This work was supported by NIH grants R01AI089728 (to F.L.) and
R01AI110700 (to R.S.B. and F.L.).
REFERENCES
1. Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus A, Fouchier
RAM. 2012. Isolation of a novel coronavirus from a man with pneumonia
in Saudi Arabia. N Engl J Med 367:1814 –1820. http://dx.doi.org/10.1056
/NEJMoa1211721.
2. de Groot RJ, Baker SC, Baric RS, Brown CS, Drosten C, Enjuanes L,
FIG 4 HKU4- and MERS-CoV-spike-mediated pseudovirus entry into bat cells. (A) HKU4 pseudoviruses bearing no mutation or the reengineered hECP motif
(N762A) were prepared in HEK293T cells and were then used to infect RSKT cells endogenously expressing bat DPP4 (Rhinolophus sinicus bat kidney cells [24]).
The cells were pretreated with indicated concentrations of ECP inhibitor (E-64d) before being infected by pseudoviruses. (B) The same HKU4 pseudoviruses
were used to infect Tb1-Lu cells (Tadarida brasiliensis bat lung cells) exogenously expressing bat DPP4 (GenBank accession no. KC249974). (C) MERS-CoV
pseudoviruses bearing no mutation or the mutant hECP motif (A763N/F764Y/N765T) were prepared in HEK293T cells and were then used to infect RSKT cells.
(D) The same MERS-CoV pseudoviruses were used to infect Tb1-Lu cells. The pseudovirus entry efficiencies were characterized by analysis of the levels of
luciferase activity accompanying the entry and were normalized against the relative amounts of spike proteins incorporated into pseudovirus particles. The
pseudovirus entry mediated by the wild-type HKU4 spike (for panels A and B) or wild-type MERS-CoV spike (for panels C and D) in the absence of the inhibitor
was taken as 100%. Error bars indicate SEM (n 4).
Yang et al.
9122 jvi.asm.org September 2015 Volume 89 Number 17Journal of Virology
Fouchier RA, Galiano M, Gorbalenya AE, Memish ZA, Perlman S,
Poon LL, Snijder EJ, Stephens GM, Woo PC, Zaki AM, Zambon M,
Ziebuhr J. 2013. Middle East respiratory syndrome coronavirus (MERS-
CoV): announcement of the Coronavirus Study Group. J Virol 87:7790 –
7792. http://dx.doi.org/10.1128/JVI.01244-13.
3. Annan A, Baldwin HJ, Corman VM, Klose SM, Owusu M, Nkrumah
EE, Badu EK, Anti P, Agbenyega O, Meyer B, Oppong S, Sarkodie YA,
Kalko EK, Lina PH, Godlevska EV, Reusken C, Seebens A, Gloza-
Rausch F, Vallo P, Tschapka M, Drosten C, Drexler JF. 2013. Human
betacoronavirus 2c EMC/2012-related viruses in bats, Ghana and Europe.
Emerg Infect Dis 19:456 – 459. http://dx.doi.org/10.3201/eid1903.121503.
4. Holmes KV, Dominguez SR. 2013. The new age of virus discovery:
genomic analysis of a novel human betacoronavirus isolated from a fatal
case of pneumonia. mBio 4:e00548-12. http://dx.doi.org/10.1128/mBio
.00548-12..
5. Lau SK, Li KS, Tsang AK, Lam CS, Ahmed S, Chen H, Chan KH, Woo
PC, Yuen KY. 2013. Genetic characterization of Betacoronavirus lineage
C viruses in bats reveals marked sequence divergence in the spike protein
of pipistrellus bat coronavirus HKU5 in Japanese pipistrelle: implications
for the origin of the novel Middle East respiratory syndrome coronavirus.
J Virol 87:8638 – 8650. http://dx.doi.org/10.1128/JVI.01055-13.
6. Perlman S, Netland J. 2009. Coronaviruses post-SARS: update on repli-
cation and pathogenesis. Nat Rev Microbiol 7:439 – 450. http://dx.doi.org
/10.1038/nrmicro2147.
7. Li F. 2015. Receptor recognition mechanisms of coronaviruses: a decade
of structural studies. J Virol 89:1954 –1964. http://dx.doi.org/10.1128/JVI
.02615-14.
8. Li WH, Wong SK, Li F, Kuhn JH, Huang IC, Choe H, Farzan M. 2006.
Animal origins of the severe acute respiratory syndrome coronavirus: in-
sight from ACE2-S-protein interactions. J Virol 80:4211– 4219. http://dx
.doi.org/10.1128/JVI.80.9.4211-4219.2006.
9. Belouzard S, Millet JK, Licitra BN, Whittaker GR. 2012. Mechanisms of
coronavirus cell entry mediated by the viral spike protein. Viruses 4:1011–
1033. http://dx.doi.org/10.3390/v4061011.
10. Heald-Sargent T, Gallagher T. 2012. Ready, set, fuse! The coronavirus
spike protein and acquisition of fusion competence. Viruses 4:557–580.
http://dx.doi.org/10.3390/v4040557.
11. Simmons G, Zmora P, Gierer S, Heurich A, Pohlmann S. 2013. Pro-
teolytic activation of the SARS-coronavirus spike protein: cutting en-
zymes at the cutting edge of antiviral research. Antiviral Res 100:605– 614.
http://dx.doi.org/10.1016/j.antiviral.2013.09.028.
12. Simmons G, Gosalia DN, Rennekamp AJ, Reeves JD, Diamond SL,
Bates P. 2005. Inhibitors of cathepsin L prevent severe acute respiratory
syndrome coronavirus entry. Proc Natl Acad Sci U S A 102:11876 –11881.
http://dx.doi.org/10.1073/pnas.0505577102.
13. Simmons G, Reeves JD, Rennekamp AJ, Amberg SM, Piefer AJ, Bates P.
2004. Characterization of severe acute respiratory syndrome-associated coro-
navirus (SARS-CoV) spike glycoprotein-mediated viral entry. Proc Natl Acad
Sci U S A 101:4240–4245. http://dx.doi.org/10.1073/pnas.0306446101.
14. Yang Y, Du L, Liu C, Wang L, Ma C, Tang J, Baric RS, Jiang S, Li F. 2014.
Receptor usage and cell entry of bat coronavirus HKU4 provide insight into
bat-to-human transmission of MERS coronavirus. Proc Natl Acad Sci U S A
111:12516–12521. http://dx.doi.org/10.1073/pnas.1405889111.
15. Gierer S, Muller MA, Heurich A, Ritz D, Springstein BL, Karsten CB,
Schendzielorz A, Gnirss K, Drosten C, Pohlmann S. 2015. Inhibition of
proprotein convertases abrogates processing of the Middle Eastern respi-
ratory syndrome coronavirus spike protein in infected cells but does not
reduce viral infectivity. J Infect Dis 211:889 – 897. http://dx.doi.org/10
.1093/infdis/jiu407.
16. Millet JK, Whittaker GR. 2014. Host cell entry of Middle East respiratory
syndrome coronavirus after two-step, furin-mediated activation of the
spike protein. Proc Natl Acad Sci U S A 111:15214 –15219. http://dx.doi
.org/10.1073/pnas.1407087111.
17. Bosch BJ, BartelinkW, Rottier PJ. 2008. Cathepsin L functionally cleaves
the severe acute respiratory syndrome coronavirus class I fusion protein
upstream of rather than adjacent to the fusion peptide. J Virol 82:8887–
8890. http://dx.doi.org/10.1128/JVI.00415-08.
18. Biniossek ML, Nagler DK, Becker-Pauly C, Schilling O. 2011. Proteomic
identification of protease cleavage sites characterizes prime and non-
prime specificity of cysteine cathepsins B, L, and S. J Proteome Res 10:
5363–5373. http://dx.doi.org/10.1021/pr200621z.
19. Li F. 2013. Receptor recognition and cross-species infections of SARS coronavi-
rus. Antiviral Res100:246–254. http://dx.doi.org/10.1016/j.antiviral.2013.08.014.
20. Li F, Li WH, Farzan M, Harrison SC. 2005. Structure of SARS corona-
virus spike receptor-binding domain complexed with receptor. Science
309:1864 –1868. http://dx.doi.org/10.1126/science.1116480.
21. Li WH, Zhang CS, Sui JH, Kuhn JH, Moore MJ, Luo SW, Wong SK,
Huang IC, Xu KM, Vasilieva N, Murakami A, He YQ, Marasco WA,
Guan Y, Choe HY, Farzan M. 2005. Receptor and viral determinants of
SARS-coronavirus adaptation to human ACE2. EMBO J 24:1634 –1643.
http://dx.doi.org/10.1038/sj.emboj.7600640.
22. Li F. 2008. Structural analysis of major species barriers between humans
and palm civets for severe acute respiratory syndrome coronavirus infec-
tions. J Virol 82:6984 – 6991. http://dx.doi.org/10.1128/JVI.00442-08.
23. Wang Q, Qi J, Yuan Y, Xuan Y, Han P, Wan Y, Ji W, Li Y, Wu Y, Wang
J, Iwamoto A, Woo PC, Yuen KY, Yan J, Lu G, Gao GF. 2014. Bat origins
of MERS-CoV supported by bat coronavirus HKU4 usage of human re-
ceptor CD26. Cell Host Microbe 16:328 –337. http://dx.doi.org/10.1016/j
.chom.2014.08.009.
24. Ge XY, Li JL, Yang XL, Chmura AA, Zhu G, Epstein JH, Mazet JK, Hu
B, Zhang W, Peng C, Zhang YJ, Luo CM, Tan B, Wang N, Zhu Y,
Crameri G, Zhang SY, Wang LF, Daszak P, Shi ZL. 2013. Isolation and
characterization of a bat SARS-like coronavirus that uses the ACE2 recep-
tor. Nature 503:535–538. http://dx.doi.org/10.1038/nature12711.
Evolution of MERS-CoV for Human Infection
September 2015 Volume 89 Number 17 jvi.asm.org 9123Journal of Virology
